mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
about
Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegenerationStem cells as cellular vehicles for gene therapy against glioblastomaDeveloping an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinicMaturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytesMDA-7/IL-24 induces Bcl-2 denitrosylation and ubiquitin-degradation involved in cancer cell apoptosisA novel splicing variant of mouse interleukin (IL)-24 antagonizes IL-24-induced apoptosisRecombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells.Cisplatin enhances protein kinase R-like endoplasmic reticulum kinase- and CD95-dependent melanoma differentiation-associated gene-7/interleukin-24-induced killing in ovarian carcinoma cellsEradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting AktMDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism.Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant gliomaPERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells.Splicing and splice factor SRp55 participate in the response to DNA damage by changing isoform ratios of target genes.MDA-7/IL-24 as a cancer therapeutic: from bench to bedside.Tumour suppressor function of MDA-7/IL-24 in human breast cancerThe development of MDA-7/IL-24 as a cancer therapeuticA first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapyMelanoma differentiation associated gene-7/interleukin-24 potently induces apoptosis in human myeloid leukemia cells through a process regulated by endoplasmic reticulum stress.Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene deliveryA serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.Myeloid cells migrate in response to IL-24.Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokineEnhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cellsStrategy for reversing resistance to a single anticancer agent in human prostate and pancreatic carcinomasMDA-7/IL-24: multifunctional cancer killing cytokineDynamic changes in host gene expression associated with H5N8 avian influenza virus infection in mice.Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer.Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo.Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma.Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis.Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.Selected approaches for rational drug design and high throughput screening to identify anti-cancer moleculesIL-24: a classic cytokine and/or a potential cure for cancer?TAT-IL-24-KDEL-induced apoptosis is inhibited by survivin but restored by the small molecular survivin inhibitor, YM155, in cancer cells.Suppression effect of recombinant adenovirus vector containing hIL-24 on Hep-2 laryngeal carcinoma cells.Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells
P2860
Q24676501-1150E7EB-66A2-4D03-9043-981608ECB6B1Q26771835-E6D90233-739E-45D1-A222-58D17996FDCBQ27694606-193DC7DA-C173-4C10-8A18-5D84D72F1333Q28269054-6759076A-EF88-49C7-9681-311DC1C23B53Q28384698-F42864B2-1459-4DBC-9C66-6B6A270655D6Q28509494-51B4B3B5-9D90-4F1F-A03F-523B8E2A78ACQ33309944-3B20BFD5-EB40-4A43-9E38-F3DBCCA19EBDQ33613377-581BD8CF-A019-48AA-AD6E-90A9E92EE24FQ33730689-7BE990ED-3814-4A03-8033-66E9D3715710Q33870560-0BA86084-B87D-4FAC-92E0-D9744F51639BQ33877402-2AA98D5E-CA9D-4F62-8ACE-1C8DF267B995Q33926871-8D7339EA-C3FC-4101-B53E-6C806782ED5BQ33930115-F4DA2532-B52A-4BCC-A2F3-D02952C3749FQ33931451-0583DFB7-A5EE-4557-BAC2-29997F5453C5Q34012411-C33B0AB1-5182-45B0-BAE6-4C3B4117DCB3Q34041932-D3F00EB9-CF10-450A-A527-7C9C5F519D3CQ34114046-9F9EEF8C-2BE7-49F4-87ED-D9AF24AA5D79Q34163896-245D80B6-5B3F-40DF-A8DF-6490F3711B7DQ34341900-F5B5D77D-58CF-45E6-9DA4-CD979EE36B78Q34359570-B95867E6-20CA-43B6-8AFD-8668CA44119BQ34616542-3E3E5B58-3073-4E1B-B274-DC2FD9FE0D25Q34701049-D3D8619E-0157-43FF-8A5C-173C9BF96472Q35141406-4F922569-CBB5-4AC8-BAE5-F9EFDC93F58FQ35142325-F8ADC019-66C6-4B38-BD53-95A35E2828F9Q35209685-44D592B8-C2B4-4E89-9D78-C104D4F8C5A5Q35587169-419D1640-EF63-429C-A9A1-663EFEA211F5Q35652389-2DF1A826-6722-4F94-BA6C-5D4ACC8F13AAQ36248193-ED46CD65-C154-4236-9FC7-65EC58E19FE5Q36291306-12F57209-5AF8-47AE-83A2-464FB6E5E965Q36387940-79E317B7-4C8E-41C0-BB37-5655289E07CEQ36437378-88E2EE87-E17A-4FA8-BD68-18AA0C60B1E9Q36701474-A026EC75-7817-4BED-AE76-494970F8D224Q36775413-929570EC-A8B2-4BC5-8EF6-213BBA369DD4Q36810258-281C091C-36C7-4B34-A25F-43AD16D3500CQ37027060-1FB2BED0-372B-48CA-91D6-F496F1EAE7F9Q37149641-16CC0220-3562-4AD4-BC37-A883DC9B9128Q37174207-075A0630-9D01-4D63-AADC-8A4395CCBEA8Q37392899-6621DFC8-678E-4868-BFAA-F548C4DD866CQ37574892-8969C9C0-20DE-4575-B940-F9CA58CF0AA2Q37586906-C162BEF2-DBA9-496F-A85B-BCB6811808CA
P2860
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
@ast
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
@en
type
label
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
@ast
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
@en
prefLabel
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
@ast
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
@en
P2093
P2860
P1476
mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine
@en
P2093
Devanand Sarkar
Irina V Lebedeva
Luni Emdad
Michael A Bachelor
Moira Sauane
Pankaj Gupta
Paul B Fisher
Steven Grant
Zao-zhong Su
P2860
P304
P356
10.1016/J.PHARMTHERA.2005.11.005
P577
2006-02-07T00:00:00Z